AngioDynamics, Inc. (ANGO) said it submitted a 510(k) application to the FDA for the AlphaVac System, a multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature. The company expects the release of the AlphaVac System in the second half of 2021, subject to FDA clearance.

Create Account

Dark

chart

exchange

Check out our Dark Pool Levels

AngioDynamics, Inc. (ANGO) said it submitted a 510(k) application to the FDA for the AlphaVac System, a multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature. The company expects the release of the AlphaVac System in the second half of 2021, subject to FDA clearance.

RTTNews | Apr 12, 2021 06:36AM EDT

06:35 Monday, April 12, 2021 (RTTNews.com) - AngioDynamics, Inc. (ANGO) said it submitted a 510(k) application to the FDA for the AlphaVac System, a multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature. The company expects the release of the AlphaVac System in the second half of 2021, subject to FDA clearance.

The AlphaVac System combines two of AngioDynamics' technologies: a new mechanical aspiration handle; the self-expanding funnel tip, and is designed to provide precise control in the removal of clot burden while minimizing patient blood loss.

Read the original article on RTTNews ( https://www.rttnews.com/3184067/angiodynamics-submits-510-k-application-for-alphavac-system-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved